Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Curex

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Curex head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 19 · Grade B

Curex

Visit Curex Full brief →

FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 86 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Curex a bad call — it's best for readers comparing oral and injectable compounded options who can obtain a written renewal quote and the applicable refund terms. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
85
Supply Reliability
95
85
Transparency
90
87
Access Breadth
93
90
Clinical Oversight
92
86
Track Record
88
81
CoreAge RxBrief Score 94 · 86Curex

Price, coverage & the tracker

CoreAge RxCurex
Brief Score94/100 (A)86/100 (B)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm the selected offer

Rate sheet: $299 monthly or $2,388 annually ($199/mo equivalent).

Separate first-month offer from $49; renewal quote requires confirmation.

Full price details

Conflicting published offers: rate sheet $299/month or $2,388 annual prepayment ($199/mo equivalent); separate offer from $49 first month

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm the selected offer

Rate sheet: $399 monthly or $3,588 annually ($299/mo equivalent).

Separate first-month offer from $149; renewal quote requires confirmation.

Full price details

Conflicting published offers: rate sheet $399/month or $3,588 annual prepayment ($299/mo equivalent); separate offer from $149 first month

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states advertised; California oral tablets only, no injections
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Curex: Monthly rate-sheet prices differ from first-month promotions and annual equivalents. Confirm the selected offer’s renewal charge and refund exceptions before paying.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.